
JAMA Ophthalmology : Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy
JAMA Network ›17:32 | Aug 7th
Interview with Ehsan Rahimy, MD, author of Mammalian Target Rapamycin Inhibition as a Therapeutic Target for Prevention of Proliferative Vitreoretinopathy. Hosted by Neil Bressler, MD. Related Conten...Show More
Recommendations